Johnson & Johnson’s Global Chair of Innovative Medicine Jennifer Taubert Announces Retirement
Jennifer Taubert, who leads Johnson & Johnson Innovative Medicine worldwide, has said she will step down from her role later this year.
The company indicated that Tom (last name not disclosed) will assume the chairmanship, ensuring continuity for the division’s pipeline and commercial activities.
In a separate move, Takeda announced that its global leader for TYK2 programs is also leaving the firm, highlighting a period of senior‑level turnover in the industry.
Both departures are being watched by investors and partners as they may influence strategic direction and ongoing collaborations.
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Jennifer Taubert announces retirement from J&J; Takeda's global TYK2 leader exits”
read at Endpoints ↗
comments(0)
5-min edit window · permanent after that